SEC Form 4 · accession 0001179110-17-000101
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen L. Zaderej
Officer — CEO · Director
Period of report
Dec 29, 2016
Accepted (ET)
Jan 3, 2017 · 5:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000805928
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 29, 2016 | A | 40,000 | $0.00 | A | 282,147 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to purchase)F2 | $8.95 | Dec 29, 2016 | A | 209,500 | A | — | Dec 29, 2026 | Common Stock | 209,500 | 209,500 | D |
Explanation of responses
- F1Represents shares underlying retention-based restricted stock units, all of which shall become vested on January 1, 2020 so long as the reporting person's employment is continuous from December 29, 2016 through January 1, 2020.
- F2All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.